What is the main business of Seli-Ed?

The main business activity of Seli-Ed focuses on wholesale of chemical products.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 23, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Warszawska 6, 15-063 Białystok.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from August 23, 2022 to December 31, 2023.

What was the revenue?

The company reported a revenue of $145,214 in 2023.

Is the company profitable?

Yes, in 2023 the company achieved a net profit of $30,069.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $107,573 in 2023, representing 100% of all operating expenses.

Seli-Edsp. z o.o.

Wholesale of chemical products

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-08-23

Share capital

5,000.00 PLN

Activity description

Seli-Ed offers products for molecular biology, cell culture, immunology, microbiology, genetics and cytogenetics. It serves hospitals, clinics, laboratories, universities, technical universities and research institutes, with specialists who help select products and answer questions.

Registered address

ul. Warszawska 6/32, 15-063 Białystok, Poland

Website

seli-ed.com

Phone

Financials

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2023, 44 days late).

2024not filed
202328/08/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 145.21kMedianUSD 895.43kAverageUSD 9.80m

Net profit

This companyUSD 30.07kMedianUSD 19.07kAverageUSD 341.02k

Operating costs

This companyUSD 107.57kMedianUSD 832.62kAverageUSD 8.90m

Assets

This companyUSD 31.81kMedianUSD 474.63kAverageUSD 5.34m

Industry

Offer

Molecular biology products
Cell culture products
Immunology products
Microbiology products
Genetics products
Cytogenetics products

Authorized Representatives

Dzmitry Selivon – Management Board Member

Nina Pratasevich – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Nina Pratasevichage 38	50	$675.31	50%
Dzmitry Selivonage 37	50	$675.31	50%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-09-02.

PKO Bank Polski
33 1020 1068 0000 1502 0395 4021
PKO Bank Polski
75 1020 1068 0000 1902 0395 4039
PKO Bank Polski
80 1020 1068 0000 1702 0395 4047

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Biocomsp. z o.o.	$433,929.05	biocom.net.pl
Centergensp. z o.o.	$358,287.85	centergen.pl
Medcellsp. z o.o.	$339,369.93	medcell.pl
GSH Polskasp. z o.o.	$313,619.12	gshpolska.pl
Ekob-Tbasp. z o.o.	$257,658.44	ekobtba.pl
Labmed Solutionssp. z o.o.	$255,387.11	labmed-solutions.com
BL Medicasp. z o.o.	$148,305.98	blmedica.pl
Screenmedsp. z o.o.	$147,401.05	screenmed.pl
Bioingsp. z o.o.	$121,417.17	bioing.pl
Pharmbiopolsp. z o.o.	$99,211.10	pharmbiopol.com

Change history

Date	Event
2023-09-08	Address change (Ul. Stefana Okrzei 1a/10p, 03-715, Warszawa → Ul. Warszawska 6/32, 15-063, Białystok)
2022-08-23	Entered in the register

FAQ

Last updated: 2026-04-16